Article Text

Download PDFPDF

EPV088/#577 Overall survival and time trends in cervical cancer in Almaty, Kazakhstan
  1. R Bolatbekova1,
  2. D Kaidarova2,
  3. N Izbagambetov1,
  4. T Valiyeva1,
  5. Y Kukubassov3,
  6. A Aidarov1,
  7. G Bagatova1,
  8. B Kudaibergenova1,
  9. A Satanova3 and
  10. A Sarmenova1
  1. 1Almaty Oncology Center, Oncogynecology, Almaty, Kazakhstan
  2. 2Kazakh Institute of Oncology and Radiology, Head of Kazior, Almaty, Kazakhstan
  3. 3Kazakh Institute of Oncology and Radiology, Oncogynecology, Almaty, Kazakhstan


Objectives In Kazakhstan standardized incidence of CC was 17.2 per 100,000, the mortality rate was 6 per 100,000 for 2020. The overall survival (OS) of CC in Kazakhstan was 52,5% (95%CI:50,7–54,2). The CC Screening program uses cytology (Pap-smear) from 2008 for women 30–70 years every 4 years. Almaty remains the country’s largest city with high cancer incidence and mortality. The purpose was to analyze time-trends for 2005–2020 and OS from CC in Almaty.

Methods Incidence and mortality were sourced from National Cancer Registry database. All rates were directly age-standardized. Data on survival were obtained from reports. OS was performed using the Kaplan-Meier method. The statistical analysis was performed with SPSS23.0.

Results The total number of registered women with CC in Almaty was in 2462. CC incidence is decreased from 16 to 13.4 per 100000 female population for last 15 years, Mortality i from 5.8 to 4.6 per 100000 female population. The average age of women with CC in 2016 was 50.8±11.7. 241 cases included: most of them at 1st stage-128(50.3%) 90(35.3%) in stage II, 18(7%) in stage III, 5(1,9%) in an advanced stage. 38 women were dead from CC. The OS was 81,7±0.88% (95%CI: 80,82–82,58)

Conclusions The CC incidence and mortality is lower in comparison with the republican values associated with better screening service and control in Almaty. The OS from CC in Almaty was higher than Kazakhstan regional average. Despite of positive results of CC screening, mortality rate is high compared to developed countries, which makes it necessary to introduce HPV-screening and HPV-vaccination

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.